COMBINATION VERSUS SEQUENTIAL SINGLE AGENT CHEMOTHERAPY IN ADVANCED BREAST-CANCER - ASSOCIATIONS WITH METASTATIC SITES AND LONG-TERM SURVIVAL

被引：36

作者：

CHLEBOWSKI, RT ^{[1
]}

SMALLEY, RV ^{[1
]}

WEINER, JM ^{[1
]}

IRWIN, LE ^{[1
]}

BARTOLUCCI, AA ^{[1
]}

BATEMAN, JR ^{[1
]}

机构：

[1] SE CANC STUDY GRP,BIRMINGHAM,AL

来源：

BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 02期

关键词：

D O I：

10.1038/bjc.1989.46

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：227 / 230

页数：4

共 33 条

[1]

AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P877

[2] THE EFFECT ON SURVIVAL OF INITIAL CHEMOTHERAPY IN ADVANCED BREAST-CANCER - POLYCHEMOTHERAPY VERSUS SINGLE DRUG [J].

AHMANN, DL ;

SCHAID, DJ ;

BISEL, HF ;

HAHN, RG ;

EDMONSON, JH ;

INGLE, JN .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1928-1932

[3] CHEMOTHERAPY VERSUS CHEMOIMMUNOTHERAPY (CAF V CAFVP V CMF EACH +/- MER) FOR METASTATIC CARCINOMA OF THE BREAST - A CALGB STUDY [J].

AISNER, J ;

WEINBERG, V ;

PERLOFF, M ;

WEISS, R ;

PERRY, M ;

KORZUN, A ;

GINSBERG, S ;

HOLLAND, JF .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1523-1533

[4]

BAKER LH, 1974, CANCER-AM CANCER SOC, V33, P513, DOI 10.1002/1097-0142(197402)33:2<513::AID-CNCR2820330228>3.0.CO

[5]

2-H

[6]

CANELLOS GP, 1976, CANCER, V38, P1982

[7]

CHLEBOWSKI RT, 1979, CANCER RES, V39, P4503

[8] FACTORS INFLUENCING THE INTERIM INTERPRETATION OF A BREAST-CANCER TRIAL - DANGER OF ACHIEVING THE EXPECTED RESULT [J].

CHLEBOWSKI, RT ;

WEINER, JM ;

RYDEN, VMJ ;

BATEMAN, JR .

CONTROLLED CLINICAL TRIALS, 1981, 2 (02) :123-132

[9]

COOPER RG, 1969, P AM ASSOC CANC RES, V10, P15

[10] METAANALYSIS IN CLINICAL-TRIALS [J].

DERSIMONIAN, R ;

LAIRD, N .

CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188

← 1 2 3 4 →